In pediatric B-ALL, SETD2 loss-of-function mutations were first reported by Mar et al., occurring in approximately 12% of cases at diagnosis, particularly enriched in MLLr and ETV6::RUNX1 subtypes [22]. The gene discussed is SETD2; the disease is precursor B-cell acute lymphoblastic leukemia.